ATE194753T1 - Hyperkinetische bewegungsstörung modulierender opiatrezeptor-antagonist - Google Patents

Hyperkinetische bewegungsstörung modulierender opiatrezeptor-antagonist

Info

Publication number: ATE194753T1
Authority: AT; Austria
Prior art keywords: receptor antagonist; movement disorder; opiator; modulating; hyperkinetic movement
Prior art date: 1991-02-25

Application number

AT92907704T

Other languages

English (en)

Inventor

Conan Kornetsky

Original Assignee

Univ Boston

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1991-02-25

Filing date

1992-02-25

Publication date

2000-08-15

1992-02-25 Application filed by Univ Boston filed Critical Univ Boston

2000-08-15 Application granted granted Critical

2000-08-15 Publication of ATE194753T1 publication Critical patent/ATE194753T1/de

Links

208000000269 Hyperkinesis Diseases 0.000 title abstract 2
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title abstract 2
239000002464 receptor antagonist Substances 0.000 title 1
229940044551 receptor antagonist Drugs 0.000 title 1
239000003401 opiate antagonist Substances 0.000 abstract 2
208000023105 Huntington disease Diseases 0.000 abstract 1
206010043118 Tardive Dyskinesia Diseases 0.000 abstract 1
230000002068 genetic effect Effects 0.000 abstract 1
239000003176 neuroleptic agent Substances 0.000 abstract 1
230000000701 neuroleptic effect Effects 0.000 abstract 1
230000001107 psychogenic effect Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Psychiatry (AREA)
Emergency Medicine (AREA)
Epidemiology (AREA)
Addiction (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

AT92907704T 1991-02-25 1992-02-25 Hyperkinetische bewegungsstörung modulierender opiatrezeptor-antagonist ATE194753T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US66054391A	1991-02-25	1991-02-25
PCT/US1992/001418 WO1992014364A1 (en)	1991-02-25	1992-02-25	Opiate receptor antagonist modulates hyperkinetic movement disorder

Publications (1)

Publication Number	Publication Date
ATE194753T1 true ATE194753T1 (de)	2000-08-15

Family

ID=24649948

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT92907704T ATE194753T1 (de)	1991-02-25	1992-02-25	Hyperkinetische bewegungsstörung modulierender opiatrezeptor-antagonist

Country Status (9)

Country	Link
US (1)	US6153620A (de)
EP (1)	EP0573565B1 (de)
JP (1)	JPH06505747A (de)
AT (1)	ATE194753T1 (de)
AU (1)	AU658401B2 (de)
CA (1)	CA2104229C (de)
DE (1)	DE69231274T2 (de)
ES (1)	ES2148174T3 (de)
WO (1)	WO1992014364A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9815618D0 (en) *	1998-07-18	1998-09-16	Univ Manchester	Treatment of dyskinesia
PL2368554T3 (pl)	2003-04-08	2015-05-29	Progenics Pharm Inc	Preparaty farmaceutyczne zawierające metylonaltrekson
US8524731B2 (en)	2005-03-07	2013-09-03	The University Of Chicago	Use of opioid antagonists to attenuate endothelial cell proliferation and migration
MX2007010833A (es)	2005-03-07	2009-02-17	Univ Chicago	Uso de antagonistas opioides para atenuar proliferacion y migracion de células endoteliales.
US9662325B2 (en)	2005-03-07	2017-05-30	The University Of Chicago	Use of opioid antagonists to attenuate endothelial cell proliferation and migration
US8518962B2 (en)	2005-03-07	2013-08-27	The University Of Chicago	Use of opioid antagonists
AR057035A1 (es)	2005-05-25	2007-11-14	Progenics Pharm Inc	SíNTESIS DE (R)-N-METILNALTREXONA, COMPOSICIONES FARMACÉUTICAS Y USOS
AR057325A1 (es)	2005-05-25	2007-11-28	Progenics Pharm Inc	Sintesis de (s)-n-metilnaltrexona, composiciones farmaceuticas y usos
TWI489984B (zh)	2006-08-04	2015-07-01	Wyeth Corp	用於非經腸道傳輸化合物之配方及其用途
JP5469593B2 (ja)	2007-03-29	2014-04-16	ワイス・エルエルシー	末梢性オピオイド受容体アンタゴニストおよびその使用
MX2009010550A (es)	2007-03-29	2009-12-14	Progenics Pharm Inc	Formas de cristal de bromuro de (r)-n-metilnaltrexona y uso de las mismas.
WO2008121348A2 (en)	2007-03-29	2008-10-09	Progenics Pharmaceuticals, Inc.	Peripheral opioid receptor antagonists and uses thereof
MX2009011449A (es) *	2007-04-24	2010-01-25	Toray Industries	Agente terapeutico o profilactico para disquinesia.
WO2009052072A1 (en) *	2007-10-18	2009-04-23	Allergan, Inc.	Treating motor disorders with 4-(1-(2,3-dimethylphenyl)ethyl)-1h-imidazole-2(3h)-thione
AU2008349873B2 (en)	2008-02-06	2014-02-13	Progenics Pharmaceuticals, Inc.	Preparation and use of (R),(R)-2,2'-bis-methylnaltrexone
CA2719134C (en)	2008-03-21	2015-06-30	The University Of Chicago	Treatment with opioid antagonists and mtor inhibitors
CA2676881C (en)	2008-09-30	2017-04-25	Wyeth	Peripheral opioid receptor antagonists and uses thereof
GB2543271A (en) *	2015-10-12	2017-04-19	Lars Holger Hermann Dr	Products for treating psychogenic pain disorders

1992
- 1992-02-25 ES ES92907704T patent/ES2148174T3/es not_active Expired - Lifetime
- 1992-02-25 DE DE69231274T patent/DE69231274T2/de not_active Expired - Fee Related
- 1992-02-25 AU AU14563/92A patent/AU658401B2/en not_active Ceased
- 1992-02-25 AT AT92907704T patent/ATE194753T1/de not_active IP Right Cessation
- 1992-02-25 CA CA002104229A patent/CA2104229C/en not_active Expired - Fee Related
- 1992-02-25 WO PCT/US1992/001418 patent/WO1992014364A1/en not_active Ceased
- 1992-02-25 JP JP4507357A patent/JPH06505747A/ja active Pending
- 1992-02-25 EP EP92907704A patent/EP0573565B1/de not_active Expired - Lifetime
1993
- 1993-01-21 US US08/006,691 patent/US6153620A/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
DE69231274D1 (de)	2000-08-24
EP0573565A4 (de)	1994-03-18
US6153620A (en)	2000-11-28
CA2104229A1 (en)	1992-08-26
JPH06505747A (ja)	1994-06-30
WO1992014364A1 (en)	1992-09-03
AU658401B2 (en)	1995-04-13
DE69231274T2 (de)	2000-11-30
EP0573565B1 (de)	2000-07-19
AU1456392A (en)	1992-09-15
EP0573565A1 (de)	1993-12-15
CA2104229C (en)	1997-04-15
ES2148174T3 (es)	2000-10-16

Legal Events

Date	Code	Title	Description
2001-02-15	UEP	Publication of translation of european patent specification
2002-11-15	REN	Ceased due to non-payment of the annual fee

Publication	Publication Date	Title
DE69231274D1 (de)	2000-08-24	Hyperkinetische bewegungsstörung modulierender opiatrezeptor-antagonist
MY107158A (en)	1995-09-30	3-arylcarbonyl; -1h-indoles useful as therapeutic agents.
GB2270075B (en)	1995-01-04	Substituted 2-phenyl-3-methoxypropenoate fungicides
FI932254A7 (fi)	1993-07-02	Menetelmä dipalmitoyylifosfaridyylikoliinidispersioiden antamiseksi
FI960727A0 (fi)	1996-02-16	Neurokiniiniantagonisteina käyttökelpoiset heterosyklit
MX9802383A (es)	1998-08-30	Derivados de pirimidina como antagonistas del receptor 5ht26.
SE9003665D0 (sv)	1990-11-16	Morphine prodrugs
MX9800125A (es)	1998-03-31	Nuevas composiciones medicinales estables para generar aerosoles libres de gas propulsor.
NO974258D0 (no)	1997-09-15	IL-17-reseptor
DZ1763A1 (fr)	2002-02-17	Composition vaccinantes.
BG101194A (en)	1998-04-30	New heteroaryl oxazolidinons
EA200100022A1 (ru)	2001-06-25	Композиции с контролируемым высвобождением пароксетина
EP0929319A4 (de)	1999-07-21
EP0691037A4 (de)	1996-04-24	Elektrochemisches fullerensystem
TR199700834T1 (xx)	1998-01-21	1-Aril-2-Akilamino ethan bile�ikleri ve bunlar�n n�rokinin olarak �zellikle n�rokinin 1 has�mlar� olarak kullan�mlar�.
TR200001102T2 (tr)	2000-08-21	İkameli tetrahidropirimidinen türevleri, üretimleri ve kullanımları.
YU48915B (sh)	2002-11-15	Sulfonilkarbamid i postupak za njegovo dobijanje
FR2693911B1 (fr)	1995-06-02	Nouvelles utilisations d'un appareillage d'électro-anesthésie.
SE9504662D0 (sv)	1995-12-22	New compounds
DE69201906D1 (de)	1995-05-11	Zylinderbüchse.
ATE227122T1 (de)	2002-11-15	Stabilisierte tablettenformulierung
DE69202890D1 (de)	1995-07-20	Zylinderlaufbüchse.
FI921457A0 (fi)	1992-04-02	Svetsanordning foer roer.
NO981188D0 (no)	1998-03-17	5-HT3-reseptorantagonister for dyskinesi
SE9304236D0 (sv)	1993-12-22	New use